226 related articles for article (PubMed ID: 21872478)
1. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
Xu B; Huang Z; Liu C; Cai Z; Pan W; Cao P; Hao X; Liang G
Bioorg Med Chem; 2009 Apr; 17(8):3118-25. PubMed ID: 19307124
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Matijin-Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents.
Qiu J; Xu B; Gong Q; Pan W; Liu C; Huang Z; Gu X; Liang G
Chem Biodivers; 2016 Nov; 13(11):1584-1592. PubMed ID: 27451105
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors.
Zhao Y; Liu Y; Chen D; Wei Z; Liu W; Gong P
Bioorg Med Chem Lett; 2010 Dec; 20(24):7230-3. PubMed ID: 21074429
[TBL] [Abstract][Full Text] [Related]
6. Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors.
Zhang Q; Jiang ZY; Luo J; Ma YB; Liu JF; Guo RH; Zhang XM; Zhou J; Niu W; Du FF; Li L; Li C; Chen JJ
Bioorg Med Chem Lett; 2009 Dec; 19(23):6659-65. PubMed ID: 19853440
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
9. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols.
Jia W; Zhao Y; Li R; Wu Y; Li Z; Gong P
Arch Pharm (Weinheim); 2009 Sep; 342(9):507-12. PubMed ID: 19637181
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents.
Guo RH; Zhang Q; Ma YB; Huang XY; Luo J; Wang LJ; Geng CA; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Bioorg Med Chem; 2011 Feb; 19(4):1400-8. PubMed ID: 21292495
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HBV activities evaluation of new ethyl 8-imidazolylmethyl-7-hydroxyquinoline-3-carboxylate derivatives in vitro.
Liu Y; Zhao Y; Zhai X; Liu X; Sun L; Ren Y; Gong P
Arch Pharm (Weinheim); 2008 Jul; 341(7):446-52. PubMed ID: 18574853
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in-vitro anti-hepatitis B virus activity of ethyl 6-bromo-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylates.
Chen D; Liu Y; Zhang S; Guo D; Liu C; Li S; Gong P
Arch Pharm (Weinheim); 2011 Mar; 344(3):158-64. PubMed ID: 21384414
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates.
Zhao C; Zhao Y; Chai H; Gong P
Bioorg Med Chem; 2006 Apr; 14(8):2552-8. PubMed ID: 16326106
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of unnatural beta-L-enantiomers of 3'-fluoro- and 3'-azido-2',3'-dideoxyguanosine derivatives.
Marchand A; Mathé C; Imbach JL; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):205-17. PubMed ID: 10772710
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols.
Jia W; Liu Y; Li W; Liu Y; Zhang D; Zhang P; Gong P
Bioorg Med Chem; 2009 Jul; 17(13):4569-74. PubMed ID: 19457674
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro.
Liu Y; Zhao Y; Zhai X; Feng X; Wang J; Gong P
Bioorg Med Chem; 2008 Jul; 16(13):6522-7. PubMed ID: 18524601
[TBL] [Abstract][Full Text] [Related]
20. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
